The pulmonary pathology of COVID-19

Uloženo v:
Podrobná bibliografie
Název: The pulmonary pathology of COVID-19
Autoři: Hans Bösmüller, Matthias Matter, Falko Fend, Alexandar Tzankov
Zdroj: Virchows Arch
Informace o vydavateli: Springer Science and Business Media LLC, 2021.
Rok vydání: 2021
Témata: Review and Perspectives, 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Lung/pathology [MeSH], COVID-19, Thrombosis/pathology [MeSH], Annual review issues from Virchows Archiv, Humans [MeSH], COVID-19/complications [MeSH], COVID-19/pathology [MeSH], Pulmonary disease, Diffuse alveolar damage, Thrombosis/virology [MeSH], Autopsy, Lung/virology [MeSH], SARS-CoV-2, Autopsy [MeSH], Humans, Thrombosis, Lung, 3. Good health
Popis: The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in the vast majority of patients. Mainly based on results obtained by autopsies, the seminal features of fatal COVID-19 have been described by many groups worldwide. Early changes encompass edema, epithelial damage, and capillaritis/endothelialitis, frequently combined with microthrombosis. Subsequently, patients with manifest respiratory insufficiency exhibit exudative diffuse alveolar damage (DAD) with hyaline membrane formation and pneumocyte type 2 hyperplasia, variably complicated by superinfection, which may progress to organizing/fibrotic stage DAD. These features, however, are not specific for COVID-19 and can be found in other disorders including viral infections. Clinically, the early disease stage of severe COVID-19 is characterized by high viral load, lymphopenia, massive secretion of pro-inflammatory cytokines and hypercoagulability, documented by elevated D-dimers and an increased frequency of thrombotic and thromboembolic events, whereas virus loads and cytokine levels tend to decrease in late disease stages, when tissue repair including angiogenesis prevails. The present review describes the spectrum of lung pathology based on the current literature and the authors’ personal experience derived from clinical autopsies, and tries to summarize our current understanding and open questions of the pathophysiology of severe pulmonary COVID-19.
Druh dokumentu: Article
Other literature type
Jazyk: English
ISSN: 1432-2307
0945-6317
DOI: 10.1007/s00428-021-03053-1
Přístupová URL adresa: https://link.springer.com/content/pdf/10.1007/s00428-021-03053-1.pdf
https://pubmed.ncbi.nlm.nih.gov/33604758
https://link.springer.com/content/pdf/10.1007/s00428-021-03053-1.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892326
https://www.scilit.net/article/7d5786f573a60184b59fa2b22450f3c7
https://link.springer.com/article/10.1007/s00428-021-03053-1
https://repository.publisso.de/resource/frl:6450050
Rights: CC BY
Přístupové číslo: edsair.doi.dedup.....ad4e774a6faf98c13cc2babed006a9a5
Databáze: OpenAIRE
Popis
Abstrakt:The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in the vast majority of patients. Mainly based on results obtained by autopsies, the seminal features of fatal COVID-19 have been described by many groups worldwide. Early changes encompass edema, epithelial damage, and capillaritis/endothelialitis, frequently combined with microthrombosis. Subsequently, patients with manifest respiratory insufficiency exhibit exudative diffuse alveolar damage (DAD) with hyaline membrane formation and pneumocyte type 2 hyperplasia, variably complicated by superinfection, which may progress to organizing/fibrotic stage DAD. These features, however, are not specific for COVID-19 and can be found in other disorders including viral infections. Clinically, the early disease stage of severe COVID-19 is characterized by high viral load, lymphopenia, massive secretion of pro-inflammatory cytokines and hypercoagulability, documented by elevated D-dimers and an increased frequency of thrombotic and thromboembolic events, whereas virus loads and cytokine levels tend to decrease in late disease stages, when tissue repair including angiogenesis prevails. The present review describes the spectrum of lung pathology based on the current literature and the authors’ personal experience derived from clinical autopsies, and tries to summarize our current understanding and open questions of the pathophysiology of severe pulmonary COVID-19.
ISSN:14322307
09456317
DOI:10.1007/s00428-021-03053-1